Ind-Swift Laboratories Ltd.
₹139.15-1.01%Apr 13, 3:45 PM IST
INDSWFTLAB•Health Technology•Pharmaceuticals: Major
Current Price
₹139.15-1.01%
Apr 13, 3:45 PM ISTMarket Cap₹1,151.13 Cr
Market Cap₹1,151.13 Cr
Business Overview
Ind-Swift Laboratories Limited operates through 3 main business divisions including API Business, CRAMS Business, Formulations Business.
Business Hierarchy Structure for Ind-Swift Laboratories Limited
- Ind-Swift Laboratories Limited
- API Business
- CRAMS Business
- Formulations Business
- Ind Swift Limited (Group Company)
- Therapeutic Segments
- Diabetology
- Cardiovascular
- Anesthesiology
- Ophthalmology
- Neuropsychiatry
- Gynaecology
- Pediatric
- ENT
- Surgery
- Internal Medicine
- Dermatology
- Urology
- Cardiology
- Dental Speciality
- Dosage Forms
- Oral solutions and suspensions
- Dry syrups and hard gelatin capsules
- Tablets
- Dermatological (creams, ointments, and gels)
- Eye and ear drops
- Injectables
- Product Basket
- Cephalosporins
- Quinolones
- Aminoglycosides
- Macrolides
- Chloramphenicol
- Tetracyclines
- Sulphonamides
- Antianaerobics
- Anti-fungal
- Therapeutic Segments
- Ind Swift Limited (Group Company)